Cargando…
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
PURPOSE: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used for the diagnosis and staging of lung cancer. However, evidence of its usefulness for re-biopsy in treated lung cancer, especially according to the previous treatment, is limited. We evaluated the ro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790847/ https://www.ncbi.nlm.nih.gov/pubmed/30913867 http://dx.doi.org/10.4143/crt.2019.031 |
_version_ | 1783458853179883520 |
---|---|
author | Kim, Joohae Kang, Hyo Jae Moon, Sung Ho Lee, Jong Mog Kim, Hyae Young Lee, Geon-Kook Lee, Jin Soo Hwangbo, Bin |
author_facet | Kim, Joohae Kang, Hyo Jae Moon, Sung Ho Lee, Jong Mog Kim, Hyae Young Lee, Geon-Kook Lee, Jin Soo Hwangbo, Bin |
author_sort | Kim, Joohae |
collection | PubMed |
description | PURPOSE: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used for the diagnosis and staging of lung cancer. However, evidence of its usefulness for re-biopsy in treated lung cancer, especially according to the previous treatment, is limited. We evaluated the role of EBUS-TBNA for re-biopsy and its diagnostic values in patients with different treatment histories. MATERIALS AND METHODS: We reviewed the medical records of patients who underwent EBUS-TBNA for re-biopsy of suspicious recurrent or progressive lesions between January 2006 and December 2016 at the National Cancer Center in South Korea. Patients were categorized into three groups based on the previous treatment modalities: surgery, radiation, and palliation. RESULTS: Among the 367 patients (surgery, n=192; radiation, n=40; palliation, n=135) who underwent EBUS-TBNA for re-biopsy, the overall sensitivity, negative predictive value (NPV), and diagnostic accuracy of EBUS-TBNA in detecting malignancy were 95.6%, 82.7%, and 96.3%, respectively. The sensitivity was lower in the radiation group (83.3%) when compared with the surgery (95.7%, p=0.042) and palliation (97.7%, p=0.012) groups. The NPV was lower in the palliation group (50.0%) than in the surgery group (88.5%, p=0.042). The sample adequacy of EBUS-TBNA specimens was lower in the radiation group (80.3%) than in the surgery (95.4%, p < 0.001) or palliation (97.8%, p < 0.001) groups. EGFR mutation analysis was feasible in 94.6% of the 92 cases, in which mutation analysis was requested. There were no major complications. Minor complications were reported in 12 patients (3.3%). CONCLUSION: EBUS-TBNA showed high diagnostic values and high suitability for EGFR mutation analysis with regard to re-biopsy in patients with previously treated lung cancer. The sensitivity was lower in the radiation group and NPV was lower in the palliation group. The complication rate was low. |
format | Online Article Text |
id | pubmed-6790847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Korean Cancer Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-67908472019-10-21 Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer Kim, Joohae Kang, Hyo Jae Moon, Sung Ho Lee, Jong Mog Kim, Hyae Young Lee, Geon-Kook Lee, Jin Soo Hwangbo, Bin Cancer Res Treat Original Article PURPOSE: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used for the diagnosis and staging of lung cancer. However, evidence of its usefulness for re-biopsy in treated lung cancer, especially according to the previous treatment, is limited. We evaluated the role of EBUS-TBNA for re-biopsy and its diagnostic values in patients with different treatment histories. MATERIALS AND METHODS: We reviewed the medical records of patients who underwent EBUS-TBNA for re-biopsy of suspicious recurrent or progressive lesions between January 2006 and December 2016 at the National Cancer Center in South Korea. Patients were categorized into three groups based on the previous treatment modalities: surgery, radiation, and palliation. RESULTS: Among the 367 patients (surgery, n=192; radiation, n=40; palliation, n=135) who underwent EBUS-TBNA for re-biopsy, the overall sensitivity, negative predictive value (NPV), and diagnostic accuracy of EBUS-TBNA in detecting malignancy were 95.6%, 82.7%, and 96.3%, respectively. The sensitivity was lower in the radiation group (83.3%) when compared with the surgery (95.7%, p=0.042) and palliation (97.7%, p=0.012) groups. The NPV was lower in the palliation group (50.0%) than in the surgery group (88.5%, p=0.042). The sample adequacy of EBUS-TBNA specimens was lower in the radiation group (80.3%) than in the surgery (95.4%, p < 0.001) or palliation (97.8%, p < 0.001) groups. EGFR mutation analysis was feasible in 94.6% of the 92 cases, in which mutation analysis was requested. There were no major complications. Minor complications were reported in 12 patients (3.3%). CONCLUSION: EBUS-TBNA showed high diagnostic values and high suitability for EGFR mutation analysis with regard to re-biopsy in patients with previously treated lung cancer. The sensitivity was lower in the radiation group and NPV was lower in the palliation group. The complication rate was low. Korean Cancer Association 2019-10 2019-03-15 /pmc/articles/PMC6790847/ /pubmed/30913867 http://dx.doi.org/10.4143/crt.2019.031 Text en Copyright © 2019 by the Korean Cancer Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kim, Joohae Kang, Hyo Jae Moon, Sung Ho Lee, Jong Mog Kim, Hyae Young Lee, Geon-Kook Lee, Jin Soo Hwangbo, Bin Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer |
title | Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer |
title_full | Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer |
title_fullStr | Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer |
title_full_unstemmed | Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer |
title_short | Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer |
title_sort | endobronchial ultrasound-guided transbronchial needle aspiration for re-biopsy in previously treated lung cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790847/ https://www.ncbi.nlm.nih.gov/pubmed/30913867 http://dx.doi.org/10.4143/crt.2019.031 |
work_keys_str_mv | AT kimjoohae endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer AT kanghyojae endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer AT moonsungho endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer AT leejongmog endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer AT kimhyaeyoung endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer AT leegeonkook endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer AT leejinsoo endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer AT hwangbobin endobronchialultrasoundguidedtransbronchialneedleaspirationforrebiopsyinpreviouslytreatedlungcancer |